Compare, Analyse Sun Pharma with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUN PHARMA vs MYLAN (US) - Comparison Results

SUN PHARMA     Change

Sun Pharma holds 3.7% share of the domestic pharma market (as per the latest ORG IMS MAT data) and has a strong presence in the lifestyle therapeutic segments. The company started focusing on the exports market in FY02, when it increased its stake to... More

MYLAN (US)
   Change

Mylan is one of the worlds leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industrys broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 SUN PHARMA   MYLAN
EQUITY SHARE DATA
    SUN PHARMA
Mar-20
MYLAN
Dec-18
SUN PHARMA/
MYLAN
5-Yr Chart
Click to enlarge
High Rs4843,512-   
Low Rs3151,933-   
Sales per share (Unadj.) Rs136.91,616.0-  
Earnings per share (Unadj.) Rs17.543.9-  
Cash flow per share (Unadj.) Rs26.0346.5-  
Dividends per share (Unadj.) Rs4.000-  
Dividend yield (eoy) %1.00-  
Book value per share (Unadj.) Rs188.71,748.2-  
Shares outstanding (eoy) m2,399.26514.50-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.91.7 173.3%   
Avg P/E ratio x22.962.0 36.9%  
P/CF ratio (eoy) x15.47.9 195.6%  
Price / Book Value ratio x2.11.6 136.0%  
Dividend payout %22.90-   
Avg Mkt Cap Rs m958,8641,400,717 68.5%   
No. of employees `00017.835.0 50.7%   
Total wages/salary Rs m63,6240-   
Avg. sales/employee Rs Th18,490.623,755.1 77.8%   
Avg. wages/employee Rs Th3,582.60-   
Avg. net profit/employee Rs Th2,357.6645.0 365.5%   
INCOME DATA
Net Sales Rs m328,375831,427 39.5%  
Other income Rs m6,3600-   
Total revenues Rs m334,735831,427 40.3%   
Gross profit Rs m69,898215,142 32.5%  
Depreciation Rs m20,528155,676 13.2%   
Interest Rs m3,02739,989 7.6%   
Profit before tax Rs m52,70219,478 270.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-2,6060-   
Tax Rs m8,228-3,099 -265.5%   
Profit after tax Rs m41,86822,577 185.4%  
Gross profit margin %21.325.9 82.3%  
Effective tax rate %15.6-15.9 -98.1%   
Net profit margin %12.82.7 469.5%  
BALANCE SHEET DATA
Current assets Rs m316,542464,268 68.2%   
Current liabilities Rs m157,064338,503 46.4%   
Net working cap to sales %48.615.1 321.1%  
Current ratio x2.01.4 146.9%  
Inventory Days Days8884 104.7%  
Debtors Days Days10593 112.2%  
Net fixed assets Rs m243,102161,283 150.7%   
Share capital Rs m2,399443 542.0%   
"Free" reserves Rs m450,2450-   
Net worth Rs m452,645899,452 50.3%   
Long term debt Rs m20,289970,797 2.1%   
Total assets Rs m682,5252,412,680 28.3%  
Interest coverage x18.41.5 1,237.9%   
Debt to equity ratio x01.1 4.2%  
Sales to assets ratio x0.50.3 139.6%   
Return on assets %6.62.6 253.7%  
Return on equity %9.22.5 368.5%  
Return on capital %11.23.2 353.3%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m46,2550-   
CASH FLOW
From Operations Rs m65,548172,771 37.9%  
From Investments Rs m-25,888-89,303 29.0%  
From Financial Activity Rs m-57,151-80,487 71.0%  
Net Cashflow Rs m-13,8571,431 -968.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 73.78 Rs / USD

Compare SUN PHARMA With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare SUN PHARMA With: STRIDES PHARMA SCIENCE  LUPIN  FULFORD INDIA  NOVARTIS  TORRENT PHARMA  



Today's Market

Sensex Opens Flat; Tata Steel Jumps 4% Post Q4 Results(09:30 am)

Asian share markets rose in early trade today after data released overnight showed the US services sector added hundreds of thousands of jobs last month.

Related Views On News

SUN PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 87.4% (Quarterly Result Update)

Feb 1, 2021 | Updated on Feb 1, 2021

For the quarter ended December 2020, SUN PHARMA has posted a net profit of Rs 19 bn (up 87.4% YoY). Sales on the other hand came in at Rs 88 bn (up 8.4% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA 2019-20 Annual Report Analysis (Annual Result Update)

Dec 11, 2020 | Updated on Dec 11, 2020

Here's an analysis of the annual report of SUN PHARMA for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

SUN PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 66.9% (Quarterly Result Update)

Nov 6, 2020 | Updated on Nov 6, 2020

For the quarter ended September 2020, SUN PHARMA has posted a net profit of Rs 19 bn (up 66.9% YoY). Sales on the other hand came in at Rs 86 bn (up 5.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

Why Did Alembic Pharma Shares Fall Today? (Views On News)

May 5, 2021

Covid-led supply disruptions of API fuel Alembic Pharma's global prospects.

SUN PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Aug 6, 2019 | Updated on Aug 6, 2019

Here's an analysis of the annual report of SUN PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

More Views on News

Most Popular

Power Grid's InvIT IPO: Key Points to Consider (Company Info)

Apr 23, 2021

In this article, we discuss the key reasons why the stock of Power Grid was in focus today.

Time to Buy Smallcaps? (Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

The Next Smallcap Winners (Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

This Fund Manager Has Taken the World by Storm. Will You Invest With Her? (Profit Hunter)

Apr 26, 2021

Should you invest with this Rockstar fund manager who has outperformed in a big way?

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Learn: How to Potentially Accumulate Rs 7 Crore in Wealth Over the Long-term
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

SUN PHARMA SHARE PRICE


May 6, 2021 10:29 AM

TRACK SUN PHARMA

  • Track your investment in SUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUN PHARMA

SUN PHARMA 8-QTR ANALYSIS

COMPARE SUN PHARMA WITH

FEATURED VIDEOS

The 'Big' Money is in this 'Small' Detail

Stability, Quality or Green Stocks for 2021?

Market Crash: Picture Abhi Baaki Hai?

It's a Great Time to Buy Gold

More Featured Videos

MARKET STATS